revealed two intra-cardiac thrombi. The larger thrombus was attached to the right ventricular CRT-lead and situated in the right atrium ( Fig. 1panels a, b: arrows pointing at pacemaker lead associated thrombus, 25 × 19 mm; LA: left atrium, RA: right atrium; RV: right ventricle). The second thrombus adhered to the LAA closure device in the left atrium ( Fig. 1panels c, d : thin arrows showing thrombus, 9 × 10 mm; bold arrows indicating LAA closure device; LV: left ventricle, CR: coumarine ridge). A patent foramen ovale was excluded. The simultaneous appearance of two thrombi in the left and the right atrium was assumed to be caused by increased, possibly paraneoplastic, hypercoagulable conditions in this patient suffering from urothelial carcinoma [1] . A large meta-analysis underlined, that in patients with cancer-associated thrombosis, low-molecular weight heparins (LMWH) reduce the recurrence of venous thromboembolism (VTE) as compared to vitamin-K antagonists, whereas direct oral anticoagulants (DOAC) do not [2] . However, a very recently published cohort study including 200 patients with cancer-associated VTE treated with rivaroxaban has suggested preserved safety and efficacy, but this study lacked of a control group and outcomes were compared with past-published data on LMWHs [3] . Still, actual recommendations on DOACs advise caution when used in cancer patients [4] . As evidence for the treatment of device-related thrombosis other than central venous catheter-associated thrombosis in patients with cancer is limited, the presented patient was referred to the regional hospital for the initiation of an anticoagulation using (low-molecular weight) heparins, in accordance to current recommendations on the treatment of cancer-associated VTE [5, 6] .
Abstract Simultaneous appearance of a pacemaker-lead associated thrombus and a left atrial appendage closure device related thrombus in a patient with urothelial carcinoma shown in a transesophageal echocardiography.
Keywords Intra-cardiac thrombus · Device-associated thrombus · Left atrial appendage closure · Transesophageal echocardiography · Paraneoplastic hypercoagulability A 84-year-old male patient underwent routine transesophageal echocardiography 5 months after closure of the left atrial appendage (LAA) using a Watchman™-Device as an alternative stroke prevention strategy in atrial fibrillation and following several bleeding complications under oral anticoagulation from an urothelial carcinoma. Immediately after closure of the LAA oral anticoagulation had been stopped and the patient remained under acetylic salicylic acid. Besides paroxysmal atrial fibrillation, he had a history of coronary artery disease with coronary artery bypass grafting 18 years and myocardial infarction 10 years ago and a moderate aortic stenosis. 5 months before, a three-chamber pacemaker was implanted for cardiac resynchronization therapy (CRT) for severely reduced systolic left ventricular function and left bundle branch block. The actual transesophageal echocardiography 
